Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Shock, Cardiogenic D012770 5 associated lipids
Shock D012769 11 associated lipids
Seizures D012640 87 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Osteosarcoma D012516 50 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Rhinitis D012220 10 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pulmonary Edema D011654 23 associated lipids
Psoriasis D011565 47 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Proteinuria D011507 30 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Polycythemia Vera D011087 13 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Ozaki Y et al. Potentiation of neutrophil biosynthesis of platelet-activating factor by cytochalasin B: evaluation of acetyltransferase activity. 1987 Nippon Ketsueki Gakkai Zasshi pmid:3687329
Ramesha CS et al. Identification and quantitation of PAF from psoriatic scales. 1987 Agents Actions pmid:3687590
Ponpipom MM et al. Structure-activity relationships of kadsurenone analogues. 1987 J. Med. Chem. pmid:3027330
Friedlander G et al. Renal effects of platelet-activating factor in the rat. 1987 Agents Actions pmid:3687594
Pritchard PH The degradation of platelet-activating factor by high-density lipoprotein in rat plasma. Effect of ethynyloestradiol administration. 1987 Biochem. J. pmid:3689334
Hill CE and Olson MS Stimulation of uric acid release from the perfused rat liver by platelet activating factor or potassium. 1987 Biochem. J. pmid:3689345
Agrawal DK and Townley RG Effect of platelet-activating factor on beta-adrenoceptors in human lung. 1987 Biochem. Biophys. Res. Commun. pmid:3030311
Hébert RL et al. Hemodynamic effects of PAF-acether on the dog kidney. 1987 Prostaglandins Leukot Med pmid:3033688
Tysnes OB et al. Neomycin inhibits agonist-stimulated polyphosphoinositide metabolism and responses in human platelets. 1987 Biochem. Biophys. Res. Commun. pmid:3034251
Barnes PJ et al. The effect of platelet activating factor on pulmonary beta-adrenoceptors. 1987 Br. J. Pharmacol. pmid:3034367
Barrio V et al. Atrial natriuretic peptide inhibits glomerular contraction induced by angiotensin II and platelet activating factor. 1987 Eur. J. Pharmacol. pmid:2952517
Camussi G et al. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin. 1987 J. Lab. Clin. Med. pmid:2955066
Lellouch-Tubiana A et al. Interactions between granulocytes and platelets with the guinea-pig lung in passive anaphylactic shock. Correlations with PAF-acether-induced lesion. 1987 Int. Arch. Allergy Appl. Immunol. pmid:3583412
Foegh ML et al. Leukotrienes, thromboxane, and platelet activating factor in organ transplantation. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959038
Patterson R et al. Evaluation of the effect of a platelet activating factor antagonist on platelet activating factor and Ascaris antigen-induced airway responses in rhesus monkeys. 1987 J. Lab. Clin. Med. pmid:3668360
Stewart AG and Piper PJ Actions of platelet-activating factor in the coronary circulation of the guinea pig in vitro. 1987 Prog. Clin. Biol. Res. pmid:3671383
Abstracts of the meeting: The role of platelet-activating factors in the immune response. Paris, France, June 25 and 26, 1987. 1987 Prostaglandins pmid:3671731
Bourgain RH et al. Arterial obstruction induced by PAF-acether (1-O-alkyl-sn-glycero-3-phosphocholine). 1987 Adv. Exp. Med. Biol. pmid:3673721
Myers AK and Bader TJ Role of adrenal steroids in the recovery from platelet activating factor challenge. 1987 Circ. Shock pmid:3677334
Hsueh W et al. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. 1987 FASEB J. pmid:3678700
Hannun YA et al. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways. 1987 J. Biol. Chem. pmid:3115982
Maguire MH and Csonka-Khalifah L Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs. 1987 Biochim. Biophys. Acta pmid:3117116
Mangold HK et al. Biologically active lipids. Semi-synthesis of 3H-labeled ether glycerophospholipids and ether glyceroglycolipids from ratfish liver oil. 1987 FEBS Lett. pmid:3609315
Blache D and Ciavatti M Rat platelet arachidonate metabolism in the presence of Ca2+, Sr2+ and Ba2+: studies using intact platelets and semi-purified phospholipase A2. 1987 Biochim. Biophys. Acta pmid:2444263
Caffrey E et al. Aggregation responses to platelet-activating factor in normal subjects. 1987 Haemostasis pmid:3609916
Baer PG and Cagen LM Platelet activating factor vasoconstriction of dog kidney. Inhibition by alprazolam. 1987 Hypertension pmid:3818022
Brunelleschi S et al. Platelet-activating factor-acether-induced relaxation of guinea pig airway muscle: role of prostaglandin E2 and the epithelium. 1987 J. Pharmacol. Exp. Ther. pmid:3478474
Bittman R et al. Synthesis and biochemical studies of analogs of platelet-activating factor bearing a methyl group at C2 of the glycerol backbone. 1987 J. Lipid Res. pmid:3611974
Terashita Z et al. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. 1987 J. Pharmacol. Exp. Ther. pmid:3612533
Levy JV Spasmogenic effect of platelet activating factor (PAF) on isolated rat stomach fundus strip. 1987 Biochem. Biophys. Res. Commun. pmid:3619905
Huber M and Keppler D Inhibition of leukotriene D4 catabolism by D-penicillamine. 1987 Eur. J. Biochem. pmid:3622511
Sugatani J et al. Platelet-activating factor stimulation of rabbit platelets is blocked by serine protease inhibitor (chymotryptic protease inhibitor). 1987 J. Biol. Chem. pmid:3106343
Nakayama R et al. Existence of endogenous inhibitors of platelet-activating factor (PAF) with PAF in rat uterus. 1987 J. Biol. Chem. pmid:3654606
Shimazaki N et al. Diketopiperazines as a new class of platelet-activating factor inhibitors. 1987 J. Med. Chem. pmid:3656347
Ruan CG et al. Studies on monoclonal antibodies against human platelets--a monoclonal antibody to human platelet glycoprotein I--SZ-2. 1987 Sci. Sin., Ser. B, Chem. Biol. Agric. Med. Earth Sci. pmid:3659897
Feuerstein G et al. Protective effect of a PAF-acether antagonist, BN 52021, in trichothecene toxicosis. 1987 Toxicol. Lett. pmid:3660430
Heinsohn C et al. The effect of bovine serum albumin on the synthesis of prostaglandin and incorporation of [3H]acetate into platelet-activating factor. 1987 Arch. Biochem. Biophys. pmid:3662526
Sperling RI et al. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. 1987 Arthritis Rheum. pmid:3663263
Siess W and Lapetina EG Phorbol esters sensitize platelets to activation by physiological agonists. 1987 Blood pmid:3663938
Homma H et al. Some unique features of the metabolic conversion of platelet-activating factor (AGEPC) to alkyl acyl PC by washed rabbit platelets. 1987 Arch. Biochem. Biophys. pmid:3101596
Takahashi H et al. [Blood coagulation disorders in thrombotic thrombocytopenic purpura--with special reference to a von Willebrand factor abnormality]. 1987 Rinsho Byori pmid:3501812
Neuwirth R et al. Effect of platelet activating factor antagonists on cultured rat mesangial cells. 1987 J. Pharmacol. Exp. Ther. pmid:3119816
Fennessy MR et al. Lipid mediators of anaphylaxis and increased airways reactivity. 1987 Clin. Exp. Pharmacol. Physiol. pmid:2824102
Brigham KL Conference summary: lipid mediators in the pulmonary circulation. 1987 Am. Rev. Respir. Dis. pmid:2820285
Lamant V et al. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. 1987 Biochem. Pharmacol. pmid:2820421
Földes-Filep E et al. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes. 1987 Biochem. Biophys. Res. Commun. pmid:2825685
Kimura Y et al. Effects of baicalein on leukotriene biosynthesis and degranulation in human polymorphonuclear leukocytes. 1987 Biochim. Biophys. Acta pmid:2825795
Vargaftig BB and Braquet PG PAF-acether today--relevance for acute experimental anaphylaxis. 1987 Br. Med. Bull. pmid:2825900
Mathur RS et al. Current concepts in asthma. 1987 J Assoc Physicians India pmid:3320019
Kochanek PM et al. Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia. 1987 Life Sci. pmid:2826947
Whatley RE et al. Production of platelet-activating factor by endothelial cells. 1987 Semin. Thromb. Hemost. pmid:3321437
Kelton JG and Murphy WG Acute thrombocytopenia and thrombosis. Heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura. 1987 Ann. N. Y. Acad. Sci. pmid:3322132
Valone FH and Johnson B Modulation of platelet-activating-factor-induced calcium influx and intracellular calcium release in platelets by phorbol esters. 1987 Biochem. J. pmid:3322269
O'Flaherty JT and Nishihira J Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils. 1987 J. Immunol. pmid:3029224
Henderson WR Lipid-derived and other chemical mediators of inflammation in the lung. 1987 J. Allergy Clin. Immunol. pmid:3031147
Ho YS et al. Chemoattractant-induced activation of c-fos gene expression in human monocytes. 1987 J. Exp. Med. pmid:3108444
Kurachi M et al. Suppression of bronchial response to platelet activating factor following taurine administration. 1987 Adv. Exp. Med. Biol. pmid:3434419
Matsuno K et al. [Cytoplasm free calcium ions as a second messenger]. 1987 Rinsho Byori pmid:3437533
Piper PJ and Stewart AG Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists. 1987 Br. J. Pharmacol. pmid:3034369
Kawamura Y et al. [A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions]. 1987 Rinsho Byori pmid:3437547
Kertscher HP and Ostermann G [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group]. 1987 Pharmazie pmid:3438334
Maudsley DJ and Morris AG Rapid intracellular calcium changes in U937 monocyte cell line: transient increases in response to platelet-activating factor and chemotactic peptide but not interferon-gamma or lipopolysaccharide. 1987 Immunology pmid:3110054
Lianos EA and Zanglis A Biosynthesis and metabolism of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in rat glomerular mesangial cells. 1987 J. Biol. Chem. pmid:3110152
Riedel A et al. The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity. 1987 Pharmacol Res Commun pmid:3441484
Bussolino F et al. Intravascular release of platelet activating factor in children with sepsis. 1987 Thromb. Res. pmid:3441909
Bull HA and Machin SJ The haemostatic function of the vascular endothelial cell. 1987 Blut pmid:3111566
Vane J and Botting R Inflammation and the mechanism of action of anti-inflammatory drugs. 1987 FASEB J. pmid:3111928
Riedel A and Mest HJ The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites. 1987 Prostaglandins Leukot Med pmid:3112804
Hartiala KT et al. Lack of correlation between calcium mobilization and respiratory burst activation induced by chemotactic factors in rabbit polymorphonuclear leukocytes. 1987 Biochem. Biophys. Res. Commun. pmid:3034265
Codde JP et al. Effects of altered prostanoid and lyso-PAF synthesis by marine oil diets on blood pressure of salt loaded spontaneously hypertensive rats. 1987 Agents Actions Suppl. pmid:3481207
Sweatt JD et al. Evidence for a role for Na+-H+ exchange in activation of human platelets by PAF. 1987 Circ. Res. pmid:2822286
Liu BN [Neoplastic membrane-toxic activity as one of the pathogenetic factors in blood cell and tumor growth changes]. 1987 Jan-Feb Patol Fiziol Eksp Ter pmid:3550649
Lurie A et al. Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets. 1987 Jul-Aug Bull Eur Physiopathol Respir pmid:3690021
Auriault C et al. The effector function of platelets is induced and regulated by T lymphocytes. 1987 Jul-Aug Ann. Inst. Pasteur Immunol. pmid:3118905
Fiedler VB et al. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. 1987 Mar-Apr Basic Res. Cardiol. pmid:3606544
Arnoux B et al. Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics. 1987 Mar-Apr Bull Eur Physiopathol Respir pmid:3607326
Berdel WE et al. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro. 1987 Nov-Dec Anticancer Res. pmid:3442414
Lakin KM et al. [Action of calcium antagonists on thrombocyte aggregation]. 1987 Sep-Oct Farmakol Toksikol pmid:2826225
Martin TR et al. Pulmonary responses to bronchoconstrictor agonists in the mouse. 1988 J. Appl. Physiol. pmid:2457008
Kuiper J et al. The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells. 1988 Biochem. Biophys. Res. Commun. pmid:3144970
Anderson G and Fennessy M Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig. 1988 Br. J. Pharmacol. pmid:3145088
Smith RJ et al. Diacylglycerols modulate human polymorphonuclear neutrophil responsiveness: effects on intracellular calcium mobilization, granule exocytosis, and superoxide anion production. 1988 J. Leukoc. Biol. pmid:2836539
Rao GH Measurement of ionized calcium in normal human blood platelets. 1988 Anal. Biochem. pmid:3382012
Banks JB et al. Evidence for protein-catalyzed transfer of platelet activating factor by macrophage cytosol. 1988 Biochim. Biophys. Acta pmid:3382692
Sato N et al. Microvascular basis of gastric mucosal protection. 1988 J. Clin. Gastroenterol. pmid:3183337
Subissi A et al. Effects of anti-asthma drugs on PAF-induced death in mice. 1988 Prostaglandins pmid:2907663
O'Neill C et al. Embryo-derived platelet-activating factor. Its diagnostic and therapeutic future. 1988 Ann. N. Y. Acad. Sci. pmid:3195924
Ninio E et al. Biosynthesis of paf-acether. XI. Regulation of acetyltransferase by enzyme-substrate imbalance. 1988 Biochim. Biophys. Acta pmid:3196734
Hsueh W and Gonzalez-Crussi F Ischemic bowel necrosis induced by platelet-activating factor: an experimental model. 1988 Methods Achiev Exp Pathol pmid:3045496
Janero DR et al. Specific binding of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) to the intact canine platelet. 1988 Thromb. Res. pmid:3413730
Altman R et al. Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation. 1988 Clin. Pharmacol. Ther. pmid:3416553
Morrison WJ and Shukla SD Desensitization of receptor-coupled activation of phosphoinositide-specific phospholipase C in platelets: evidence for distinct mechanisms for platelet-activating factor and thrombin. 1988 Mol. Pharmacol. pmid:2827000
Barnes PJ et al. Platelet-activating factor as a mediator of allergic disease. 1988 J. Allergy Clin. Immunol. pmid:3286723
Dulioust A et al. Immunoregulatory functions of paf-acether (platelet-activating factor). 1988 Prog. Clin. Biol. Res. pmid:3071809
Romero A et al. [Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)]. 1988 Rev. Esp. Fisiol. pmid:3072620
Kobayashi T et al. Metabolism and disposition of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate (MOTP) in rats and dogs. 1988 Xenobiotica pmid:3354232
Berstad A et al. Effect of platelet-activating factor and its receptor antagonist, SRI 63-675, on gastric bleeding in rats. 1988 Scand. J. Gastroenterol. pmid:3262915
Ryan US et al. Influence of vasoactive agents on cytoplasmic free calcium in vascular endothelial cells. 1988 J. Appl. Physiol. pmid:3209566
Nogami M et al. [Effects of a platelet activating factor (PAF) antagonist CV-3988 on acute gastric erosions in rats by water immersion and restrained stress, and by ethanol]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3210345
Shirinsky VP et al. Agonist-induced polyphosphoinositide breakdown in cultured human endothelial and vascular smooth muscle cells. 1988 Health Psychol pmid:2854052